Fig. 4: Survival outcomes according to CH or ctDNA detection.
From: Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma
a, b Overall survival (OS) for patients with mUC or mRCC, stratified by ctDNA detection. c, d OS stratified by CH detection. e Forest plot from multivariable Cox Proportional Hazards model. f CH prevalence in patients with mRCC stratified by occurrence of immune-related adverse events. P values are derived from Fisher’s Exact Test.
